Abstract:Abstract The androgen receptor (AR) transcription factor plays a key role in the development and progression of prostate cancer. Inhibition of its ligand by androgen deprivation therapy (ADT) is consequently the main medical treatment of invasive prostate cancer. AR is activated and maintained throughout prostate cancer progression even in castration resistant prostate cancer (CRPC). Prostate cancer cells escape from ADT using a variety of mechanisms. The AR and target genes have therefore become even more focused therapeutic targets in aggressive and disseminated prostate cancer. AR and its classical target genes, such as KLK3 (PSA) are, however, efficiently shut off in basal epithelial prostate cells and possibly in prostate cancer stem cells (CSCs). To investigate mechanisms of AR and AR target gene activation in different subpopulations of prostate cancer cells, several androgen response elements (ARE) reporter vectors were developed. Three ARE reporter vectors were constructed with different ARE consensus sequences in promoters linked to either fluorescence or luciferase reporter genes in lentiviral vector backbones. Cell lines transduced with the different vectors expressed the reporters in an androgen-dependent way according to fluorescence microscopy, flow cytometry and multi-well fluorescent and luminescence recording. The 241B promoter sequence reporter was selected among the constructed ARE reporters on the basis of higher activity in initial screenings. The AR positive and androgen responsive prostate cancer cell line, LNCaP, and the prostate transit amplifying epithelial cell line, EP156T-AR with exogenous AR, were transduced with the lentiviral 241B-mCherry fluorescence reporter. Flow cytometry, multi-well reader and fluorescence microscopy results corresponded when reporter cells were treated with androgen and with the AR antagonist, enzalutamide, and with the anti-androgen, abiraterone. An SV40-promoter GFP reporter element was next cloned into the 241B-mCherry reporter. Constitutive expression of GFP facilitated normalization of ARE driven mCherry fluorescent signals. Furthermore, AR expression vectors were also constructed with the AR open reading frames cloned into lentiviral expression vectors and used in co-transfection and co-transduction experiments in AR negative cell types. The developed ARE reporter system will help us to investigate the role of the AR in differentiation and proliferation of prostate cells and to study the AR activity in two and three dimensional cell cultures. This system can also be useful in screening for drugs with activity against the AR. Citation Format: Waqas Azeem, Margrete R. Hellem, Jan R. Olsen, Yaping Hua, Kristo Marvyin, Lisha Li, Yi Qu, Biaoyang Lin, Xisong Ke, Anne M. Oyan, Karl-Henning Kalland. Assays for androgen receptor activity using cell based ARE reporter systems. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2902.

Identification of Retinoid Acid Induced 16 As a Novel Androgen Receptor Target in Prostate Cancer Cells

Correction: Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer.

An Androgen Response Element Driven Reporter Assay for the Detection of Androgen Receptor Activity in Prostate Cells

Abstract 79: an Androgen Response Element-Based Reporter Assay for the Detection of Androgen Receptor Activity in Prostate Cells

Abstract 2902: Assays for Androgen Receptor Activity Using Cell Based ARE Reporter Systems

Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling Through Critical Pathways to Regulate Cell Viability in Prostate Cancer

Isolation and Characterization of Androgen Receptor Mutant, AR(M749L), with Hypersensitivity to 17-Β Estradiol Treatment

Identification and Characterization of a Novel Androgen Receptor Coregulator ARA267-α in Prostate Cancer Cells

Abstract 6282: Novel androgen related gene network in prostate cancer cell model

Integrated Expression Profiling And Chip-Seq Analyses Of The Growth Inhibition Response Program Of The Androgen Receptor

Palmitoylome Profiling Indicates That Androgens Regulate the Palmitoylation of Α‑tubulin in Prostate Cancer‑derived LNCaP Cells and Supernatants

Abstract 2458: the Androgen Receptor-Regulated Lncrna Landscape Reveals a Role Forarlnc1in Prostate Cancer Progression

Transcriptional suppression of androgen receptor by 18β-glycyrrhetinic acid in LNCaP human prostate cancer cells

A Novel Androgen Receptor (ar) Suppressor Complex (Ars)-an Essential Factor in Androgen-Independent Progression of Prostate Cancer (Pc)

Analysis of the Androgen Receptor-Regulated Lncrna Landscape Identifies a Role for ARLNC1 in Prostate Cancer Progression

Androgen receptor cofactors: A potential role in understanding prostate cancer

Interrogating Androgen Receptor Function in Recurrent Prostate Cancer

Identification of androgen response‐related lncRNAs in prostate cancer

Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening

Identification of Androgen Receptor Variant 7-related RNAs Affecting Abiraterone Efficacy in Castration-resistant Prostate Cancer Treatment by RNA-sequencing

Androgen Receptor is a Potential Therapeutic Target for Bladder Cancer